Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Nonino

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Technology Assessment in Health Care|June 29, 2017
GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONSElena Parmelli, Laura Amato, Andrew D Oxman, et al.
BMJ Neurology Open|August 5, 2025
Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: a systematic reviewIlaria Cani, Nicola Grotteschi, Giovanna Calandra-Buonaura, et al.
Journal of Clinical Epidemiology|November 21, 2025
Guideline organizations' guidance documents paper 5: conflict of interest and fundingJoanne Khabsa, Zeina Itani, Hussein A Noureldine, et al.
The Cochrane Database of Systematic Reviews|April 15, 2026
Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's diseaseFrancesco Nonino, Silvia Minozzi, Luisa Sambati, et al.
Parkinsonism & Related Disorders|June 6, 2021
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort studyRoberto D'Alessandro, Corrado Zenesini, Elisa Baldin, et al.
BMC Health Services Research|October 2, 2007
Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in ItalyNicola Magrini, Giulio Formoso, Anna Maria Marata, et al.
Frontiers in Medicine|April 1, 2025
Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational studyEnrico Costa, Vittorio Del Grosso, Bernadette Cappello, et al.
Epilepsia|July 2, 2022
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, ItalyLorenzo Muccioli, Corrado Zenesini, Lisa Taruffi, et al.
Journal of Clinical Epidemiology|May 5, 2023
GRADE concept 4: rating the certainty of evidence when study interventions or comparators differ from PICO targetsMarius Goldkuhle, Gordon H Guyatt, Nina Kreuzberger, et al.
Journal of Clinical Medicine|September 27, 2025
Hypertension, Diabetes and Depression as Modifiable Risk Factors for Dementia: A Common Data Model Approach in a Population-Based Cohort, with Study Protocol and Preliminary ResultsCorrado Zenesini, Silvia Cascini, Roberta Picariello, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Technology Assessment in Health Care|June 29, 2017
GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONSElena Parmelli, Laura Amato, Andrew D Oxman, et al.
BMJ Neurology Open|August 5, 2025
Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: a systematic reviewIlaria Cani, Nicola Grotteschi, Giovanna Calandra-Buonaura, et al.
Journal of Clinical Epidemiology|November 21, 2025
Guideline organizations' guidance documents paper 5: conflict of interest and fundingJoanne Khabsa, Zeina Itani, Hussein A Noureldine, et al.
The Cochrane Database of Systematic Reviews|April 15, 2026
Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's diseaseFrancesco Nonino, Silvia Minozzi, Luisa Sambati, et al.
Parkinsonism & Related Disorders|June 6, 2021
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort studyRoberto D'Alessandro, Corrado Zenesini, Elisa Baldin, et al.
BMC Health Services Research|October 2, 2007
Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in ItalyNicola Magrini, Giulio Formoso, Anna Maria Marata, et al.
Frontiers in Medicine|April 1, 2025
Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational studyEnrico Costa, Vittorio Del Grosso, Bernadette Cappello, et al.
Epilepsia|July 2, 2022
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, ItalyLorenzo Muccioli, Corrado Zenesini, Lisa Taruffi, et al.
Journal of Clinical Epidemiology|May 5, 2023
GRADE concept 4: rating the certainty of evidence when study interventions or comparators differ from PICO targetsMarius Goldkuhle, Gordon H Guyatt, Nina Kreuzberger, et al.
Journal of Clinical Medicine|September 27, 2025
Hypertension, Diabetes and Depression as Modifiable Risk Factors for Dementia: A Common Data Model Approach in a Population-Based Cohort, with Study Protocol and Preliminary ResultsCorrado Zenesini, Silvia Cascini, Roberta Picariello, et al.
Pageof 5